Stuart Lanham
Overview
Explore the profile of Stuart Lanham including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
146
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim Y, Kanczler J, Lanham S, Rawlings A, Roldo M, Tozzi G, et al.
Biodes Manuf
. 2024 Mar;
7(2):121-136.
PMID: 38497056
Graphic Abstract: Supplementary Information: The online version contains supplementary material available at 10.1007/s42242-023-00265-z.
2.
Kater A, Arslan O, Demirkan F, Herishanu Y, Ferhanoglu B, Diaz M, et al.
Lancet Oncol
. 2024 Mar;
25(4):463-473.
PMID: 38467131
Background: Most patients with chronic lymphocytic leukaemia progress after treatment or retreatment with targeted therapy or chemoimmunotherapy and have limited subsequent treatment options. Response levels to the single-agent venetoclax in...
3.
Matthews E, Lanham S, White K, Kyriazi M, Alexaki K, El-Sagheer A, et al.
J Tissue Eng
. 2023 May;
14:20417314231169375.
PMID: 37216034
There is a wealth of data indicating human bone marrow contains skeletal stem cells (SSC) with the capacity for osteogenic, chondrogenic and adipogenic differentiation. However, current methods to isolate SSCs...
4.
Chiodin G, Drennan S, Martino E, Ondrisova L, Henderson I, Del Rio L, et al.
Blood Adv
. 2022 May;
6(18):5494-5504.
PMID: 35640238
Chronic lymphocytic leukemia (CLL) cells have variably low surface IgM (sIgM) levels/signaling capacity, influenced by chronic antigen engagement at tissue sites. Within these low levels, CLL with relatively high sIgM...
5.
Xavier M, Kyriazi M, Lanham S, Alexaki K, Matthews E, El-Sagheer A, et al.
ACS Nano
. 2021 Mar;
15(4):6909-6916.
PMID: 33751885
Human bone marrow (BM)-derived stromal cells contain a population of skeletal stem cells (SSCs), with the capacity to differentiate along the osteogenic, adipogenic, and chondrogenic lineages, enabling their application to...
6.
Abu Awwad H, Thiagarajan L, Kanczler J, Amer M, Bruce G, Lanham S, et al.
J Control Release
. 2020 Jul;
325:335-346.
PMID: 32629135
Additive manufacturing processes used to create regenerative bone tissue engineered implants are not biocompatible, thereby restricting direct use with stem cells and usually require cell seeding post-fabrication. Combined delivery of...
7.
Orriss I, Lanham S, Savery D, Greene N, Stanier P, Oreffo R, et al.
Sci Rep
. 2018 Feb;
8(1):3325.
PMID: 29463853
Fractures are a common comorbidity in children with the neural tube defect (NTD) spina bifida. Mutations in the Wnt/planar cell polarity (PCP) pathway contribute to NTDs in humans and mice,...
8.
Lanham S, Cagampang F, Oreffo R
PLoS One
. 2015 Sep;
10(9):e0138730.
PMID: 26381752
Studies suggest bone growth & development and susceptibility to vascular disease in later life are influenced by maternal nutrition, during intrauterine and early postnatal life. There is evidence for a...
9.
Tayton E, Purcell M, Smith J, Lanham S, Howdle S, Shakesheff K, et al.
J Biomed Mater Res A
. 2014 Jul;
103(4):1346-56.
PMID: 25044983
The development of an osteogenic bone graft substitute has important practical and cost implications in many branches of medicine where bone regeneration is required. Previous in vitro and small animal...
10.
Tayton E, Fahmy S, Purcell M, Aarvold A, Smith J, Kalra S, et al.
J Biomed Mater Res A
. 2012 Jun;
100(12):3211-9.
PMID: 22707404
Impaction bone grafting (IBG) with human allograft remains the preferred approach for replacement of lost bone stock during revision hip surgery. Associated problems include cost, disease transmission, and stem subsidence....